Because A549 and 95D have the highest levels of CYTOR among all the NSCLC cell lines, two shRNAs specifically targeting CYTOR were used to knockdown CYTOR expression in A549 and 95D cells (Figure 2A). This evidence concerns the gene CYTOR and non-small cell lung carcinoma.